McGlone Suttner Wealth Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,774
Closed -$16.4K 449
2023
Q4
$16.4K Buy
+1,774
New +$14.5K ﹤0.01% 466

Other funds holding HCAT

McGlone Suttner Wealth Management's HCAT Position: Q1 2024 in Review

McGlone Suttner Wealth Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 1,774 shares — an estimated $16.4K sold.

McGlone Suttner Wealth Management first reported a position in HCAT in Q4 2023 and held it in 1 quarter. The position peaked at $16.4K in Q4 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • McGlone Suttner Wealth Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 1,774 Health Catalyst shares in Q1 2024, an estimated $16.4K.
  • McGlone Suttner Wealth Management first reported a position in Health Catalyst in Q4 2023 and held it in 1 quarter.
  • McGlone Suttner Wealth Management's Health Catalyst position peaked at $16.4K in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.